Related Experiment Video
Updated: May 8, 2026

Granulocyte-dependent Autoantibody-induced Skin Blistering
Published on: October 12, 2012
Allergic reaction to abciximab with atypical manifestations
Abdulrahman M Al-Moghairi1, Moheeb A Abdullah
1Riyadh Military Hospital, Prince Sultan Cardiac Centre (PSCC), Adult Cardiology Department, Riyadh 11427, Saudi Arabia.
Abstract:
Abciximab (ReoPro, Eli Lilly and Company, Indianapolis, Indiana) is an intravenous agent that had been approved for treatment of acute coronary syndrome undergoing coronary interventions. It is a chimeric monoclonal antibody fragment that binds to the glycoprotein IIb/IIIa receptor with a potential for the development of an immune response to variable portions within the antigen binding site following its administration. We describe a 58-year-old man who developed sudden headache, short of breath, choking and restlessness after receiving Abciximab for coronary intervention. Discontinuation of abciximab and administration of intravenous fluids, steroid and antihistamines led to improvement of his symptoms gradually.
Related Concept Videos
Hypersensitivity Reactions: Immune-Complex Reactions
Allergic Reactions: Anaphylaxis
Allergic Drug Reactions
Drug Toxicity: Allergic Reactions
Allergic Reactions
Hypersensitivities
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...